283 related articles for article (PubMed ID: 25465164)
21. [Minimal change nephrotic syndrome in adults].
Galicia Basart M; Vallés Prats M; Ferrer Prevosti E; Piera Robert L
Med Clin (Barc); 1989 Feb; 92(7):250-3. PubMed ID: 2716406
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital].
Mori D; Shinzawa M; Namba T; Yamaguchi Y; Itano S; Imakita N; Matsuda J; Murata H; Takeji M; Yamamoto R; Isaka Y; Yamauchi A
Nihon Jinzo Gakkai Shi; 2012; 54(7):1023-30. PubMed ID: 23234214
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of heavy proteinuria in patients under 2 years of age.
Chang JW; Lin CY
Pediatr Nephrol; 2003 Oct; 18(10):1044-8. PubMed ID: 12898378
[TBL] [Abstract][Full Text] [Related]
24. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of primary nephrotic syndrome in Egyptian children.
Kaddah A; Sabry S; Emil E; El-Refaey M
J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
[TBL] [Abstract][Full Text] [Related]
27. Long-term Outcome of Adult Onset Idiopathic Minimal Change Disease.
Colattur SN; Korbet SM
Saudi J Kidney Dis Transpl; 2000; 11(3):334-44. PubMed ID: 18209325
[TBL] [Abstract][Full Text] [Related]
28. Clinico-biochemical Profile of Biopsy-proven Minimal Change Disease in Adults from a Tertiary Care Center in South India.
Udupa KRN; Eshwarappa M; Gurudev KC; Gireesh MS; Reddy R; Yousuff M
Saudi J Kidney Dis Transpl; 2023 May; 34(3):242-249. PubMed ID: 38231719
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
Zhou J; Zhang Y; Liu G; Li J; Xu R; Huang J
Clin Nephrol; 2013 Aug; 80(2):121-9. PubMed ID: 23458173
[TBL] [Abstract][Full Text] [Related]
32. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K
Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956
[TBL] [Abstract][Full Text] [Related]
33. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
[TBL] [Abstract][Full Text] [Related]
34. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
36. Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.
Guitard J; Hebral AL; Fakhouri F; Joly D; Daugas E; Rivalan J; Guigonis V; Ducret F; Presne C; Pirson Y; Hourmant M; Glachant JC; Vendrely B; Moranne O; Faguer S; Chauveau D
Nephrol Dial Transplant; 2014 Nov; 29(11):2084-91. PubMed ID: 24920841
[TBL] [Abstract][Full Text] [Related]
37. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
[TBL] [Abstract][Full Text] [Related]
38. Relapse of nephrotic syndrome following remission for 20 years.
Cuoghi D; Vangelista A; Baraldi A; Cheli E
Int J Pediatr Nephrol; 1983 Sep; 4(3):211-4. PubMed ID: 6315615
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy.
Han SH; Kang EW; Park JK; Kie JH; Han DS; Kang SW
Nephrol Dial Transplant; 2011 May; 26(5):1570-5. PubMed ID: 20841490
[TBL] [Abstract][Full Text] [Related]
40. [Rapid deterioration of renal function in minimal change nephrotic syndrome].
Takeda A; Oogushi H; Matsutani H; Shimoda M; Niimura F; Narumi F; Yoneshima H
Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):173-8. PubMed ID: 2051645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
